Financhill
Back

Esperion Therapeutics Stock Predictions

S&P Global: Private Equity Invests $36 Billion Into What?

Read More
Buy
59

ESPR
Esperion Therapeutics

Last Price:
2.62
Seasonality Move:
0.34%

7 Day Trial

ALL ACCESS PASS

$ 7

Billionaire Investors Join Forces to Fund Next Generation

Learn More

Esperion Therapeutics Stock Forecast

  • Is Esperion Therapeutics Stock Undervalued?
    The current Esperion Therapeutics [ESPR] share price is $2.62. The Score for ESPR is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • ESPR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Esperion Therapeutics Stock Go Up Next Year?

Data Unavailable

Esperion Therapeutics Stock Rating

Data Unavailable

Esperion Therapeutics Stock Price History

Is ESPR stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ESPR is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Drug Manufacturers - Specialty & Generic
Sector:
Healthcare
Type:
stock
Website:
esperion.com

52-Week Data

52-Week High:
3.34
52-Week Low:
0.70

Prediction Charts

Market Cap:
483.91M
Price in USD:
2.62
Volume:
16.74M
Beta:
1.13

Technical Analysis

SMA50:
2.37
SMA100:
2.07
SMA200:
1.69
52-Wk Change:
55.65%

Stock Predictions

  • Is Esperion Therapeutics stock public?
    Yes, Esperion Therapeutics is a publicly traded company.
  • What is the Esperion Therapeutics stock quote today?
    The Esperion Therapeutics stock price is 2.62 USD today.
  • How to buy Esperion Therapeutics stock online?
    You can buy Esperion Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Mar-8 2.30 2.19 2.30 2.18
Mar-11 2.18 2.12 2.20 2.10
Mar-12 2.12 2.05 2.15 2.04
Mar-13 2.05 2.19 2.21 2.04
Mar-14 2.20 2.05 2.25 2.01
Mar-15 2.00 2.08 2.15 1.92
Mar-18 2.13 2.05 2.13 2.00
Mar-19 2.01 2.08 2.21 2.01
Mar-20 2.08 2.20 2.21 2.02
Mar-21 2.24 2.10 2.24 2.06
Mar-22 2.11 2.30 2.40 2.10
Mar-25 2.73 2.62 2.76 2.31
Mar-26 2.60 2.70 2.96 2.55
Mar-27 2.78 2.62 2.80 2.52

Esperion Therapeutics Earnings

Data Unavailable

Esperion Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.30 per share, an increase next quarter of $0.11 per share, an increase this year of $1.63 per share, and an increase next year of $0.60 per share.

* Esperion Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.